Xenon Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 8.92 M | $358.09 M | 0.39% | 11.30% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 5.40 M | $216.81 M | 0.00% | 6.84% |
| BLACKROCK, INC. | 11/12/2025 | 4.77 M | $191.55 M | -11.08% | 6.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 4.17 M | $167.39 M | -3.84% | 5.28% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 3.94 M | $158.31 M | 10.23% | 5.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 3.61 M | $144.94 M | 65.99% | 4.57% |
| BRAIDWELL LP | 11/14/2025 | 3.61 M | $144.74 M | 0.00% | 4.57% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 3.18 M | $127.74 M | 0.00% | 4.03% |
| COMMODORE CAPITAL LP | 11/14/2025 | 2.70 M | $108.41 M | -10.74% | 3.42% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 2.55 M | $102.25 M | -5.79% | 3.23% |
| HOLOCENE ADVISORS, LP | 11/14/2025 | 1.98 M | $79.36 M | 9.23% | 2.50% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 1.65 M | $66.42 M | 8.95% | 2.10% |
| STATE STREET CORP | 11/14/2025 | 1.47 M | $58.88 M | 6.23% | 1.86% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 1.40 M | $56.21 M | 27.27% | 1.77% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.40 M | $56.17 M | 11.34% | 1.77% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.38 M | $55.57 M | 56.77% | 1.75% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.26 M | $50.58 M | -14.37% | 1.60% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2025 | 1.21 M | $48.42 M | 4.64% | 1.53% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 1.20 M | $48.18 M | -11.11% | 1.52% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 1.14 M | $45.58 M | 63.02% | 1.44% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 1.10 M | $44.17 M | -45.00% | 1.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 977.44 K | $39.24 M | 0.73% | 1.24% |
| CITADEL ADVISORS LLC | 11/14/2025 | 959.10 K | $38.51 M | 698.95% | 1.21% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 851.74 K | $34.20 M | -8.58% | 1.08% |
| VANGUARD GROUP INC | 11/07/2025 | 851.39 K | $34.18 M | -2.50% | 1.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 835.10 K | $33.53 M | -35.27% | 1.06% |
| SIREN, L.L.C. | 11/13/2025 | 812.76 K | $32.63 M | 0.00% | 1.03% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 799.74 K | $32.11 M | 21.06% | 1.01% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 720.66 K | $28.93 M | 28.28% | 0.91% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 695.90 K | $27.94 M | 4.42% | 0.88% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 670.26 K | $26.91 M | 1.39% | 0.85% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 659.26 K | $26.47 M | -3.03% | 0.84% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 655.74 K | $26.33 M | 0.00% | 0.83% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 640.63 K | $25.72 M | -2.52% | 0.81% |
| MARSHALL WACE, LLP | 11/13/2025 | 611.98 K | $24.57 M | -40.02% | 0.78% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 599.11 K | $24.06 M | 678.65% | 0.76% |
| ABRDN PLC | 11/07/2025 | 579.15 K | $23.25 M | 11.06% | 0.73% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/07/2025 | 556.80 K | $22.36 M | -2.53% | 0.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 542.02 K | $21.76 M | 0.00% | 0.69% |
| FIERA CAPITAL CORP | 11/07/2025 | 520.00 K | $20.88 M | -2.01% | 0.66% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 503.70 K | $20.22 M | 7.54% | 0.64% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 503.40 K | $20.21 M | 55.66% | 0.64% |
| NORTHERN TRUST CORP | 11/14/2025 | 498.15 K | $20.00 M | 1.68% | 0.63% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 454.02 K | $18.22 M | 19.48% | 0.58% |
| CALIGAN PARTNERS LP | 11/14/2025 | 444.57 K | $17.85 M | 100.00% | 0.56% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 419.60 K | $16.85 M | -55.73% | 0.53% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 418.42 K | $16.80 M | -4.04% | 0.53% |
| CANDRIAM S.C.A. | 11/06/2025 | 396.64 K | $15.92 M | 0.00% | 0.50% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 370.21 K | $14.86 M | 0.00% | 0.47% |
| MORGAN STANLEY | 11/14/2025 | 366.57 K | $14.72 M | -5.42% | 0.46% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xenon Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 266 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc.. The most heavily invested institutionals were:
FMR LLC: 8.92 M
Avoro Capital Advisors LLC: 5.4 M
BlackRock, Inc.: 4.77 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 4.17 M
JANUS HENDERSON GROUP PLC: 3.94 M
WELLINGTON MANAGEMENT GROUP LLP: 3.61 M
106.80% of Xenon Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 90.13 M shares in the last 24 months. This purchase volume represents approximately $3.57 B in transactions.